Rocuronium for rapid sequence induction in morbidly obese patients: a prospective study for evaluation of intubation conditions after administration 1.2 mg kg⁻¹ ideal body weight of rocuronium

Eur J Anaesthesiol. 2011 Aug;28(8):609-10. doi: 10.1097/EJA.0b013e32834753d0.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Androstanols / administration & dosage*
  • Androstanols / therapeutic use
  • Bariatric Surgery / methods*
  • Female
  • Humans
  • Intubation, Intratracheal / methods*
  • Male
  • Middle Aged
  • Neuromuscular Nondepolarizing Agents / administration & dosage*
  • Neuromuscular Nondepolarizing Agents / therapeutic use
  • Obesity, Morbid / surgery*
  • Prospective Studies
  • Rocuronium
  • Single-Blind Method
  • Time Factors
  • Young Adult

Substances

  • Androstanols
  • Neuromuscular Nondepolarizing Agents
  • Rocuronium